"Urea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.
| Descriptor ID |
D014508
|
| MeSH Number(s) |
D02.948
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Urea".
Below are MeSH descriptors whose meaning is more specific than "Urea".
This graph shows the total number of publications written about "Urea" by people in this website by year, and whether "Urea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 1 | 2 |
| 1995 | 1 | 2 | 3 |
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 2 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 6 | 9 |
| 2000 | 3 | 4 | 7 |
| 2001 | 2 | 3 | 5 |
| 2002 | 3 | 5 | 8 |
| 2003 | 3 | 7 | 10 |
| 2004 | 4 | 1 | 5 |
| 2005 | 1 | 2 | 3 |
| 2006 | 6 | 6 | 12 |
| 2007 | 1 | 3 | 4 |
| 2008 | 2 | 3 | 5 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 3 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 3 | 5 | 8 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 4 | 8 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 9 | 10 |
| 2018 | 3 | 2 | 5 |
| 2019 | 1 | 2 | 3 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 3 | 5 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urea" by people in Profiles.
-
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11?+?17/18?mutations. Future Oncol. 2024; 20(27):1973-1982.
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial. Nat Med. 2024 Feb; 30(2):498-506.
-
Impact of supplementation with L-citrulline/arginine after liver transplantation in individuals with Urea Cycle Disorders. Mol Genet Metab. 2024 Mar; 141(3):108112.
-
Eradicating Helicobacter pylori via 13C-urea breath screening to prevent gastric cancer in indigenous communities: a population-based study and development of a family index-case method. Gut. 2023 11 24; 72(12):2231-2240.
-
Diagnosis and Management of Hyponatremia: A Review. JAMA. 2022 07 19; 328(3):280-291.
-
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma. ESMO Open. 2022 08; 7(4):100520.
-
Urease Levels and Gastritis Stage in Dyspeptic Patients. Acta Med Indones. 2022 Jan; 54(1):42-51.
-
Perceptions and use of phenylbutyrate metabolite testing in urea cycle disorders: Results of a clinician survey and analysis of a centralized testing database. Mol Genet Metab. 2022 01; 135(1):35-41.
-
18F-DCFPyL PET/CT in Metastatic Renal Cell Carcinoma. J Nucl Med Technol. 2022 Sep; 50(3):282-285.
-
Ripretinib for advanced gastrointestinal stromal tumor: Plain language summary of the INVICTUS study. Future Oncol. 2021 Dec 01; 17(36):5007-5012.